Following the results of the departing year, Valenta’s Ingavirin® was named among the top three products in the OTC Medication nomination.
Over 1,300 Russian and foreign manufacturers and over 5,830 brands took part in the pharmaceutical rating.
National Pharmaceutical Rating is a new format of an industry event that singles out the best players in Russia’s pharmaceutical market. The market itself brings to light leaders among companies and products, it reflects the needs and choices of patients and physicians, those, for whom the whole pharmaceutical industry works. The rating is based on syndicated research by DSM Group, a leading Russian marketing agency.